2002
Integrating cancer genomics and proteomics in the post-genome era. Proteomics. 2002;2(1):69-75.
The EZH2 polycomb transcriptional repressor--a marker or mover of metastatic prostate cancer? Cancer Cell. 2002;2(5):349-50.
DNA polymerase mu gene expression in B-cell non-Hodgkin's lymphomas: an analysis utilizing in situ hybridization. Am J Pathol. 2002;161(4):1349-55.
Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas. J Pathol. 2002;198(4):450-7.
Surgical staging in patients with ovarian tumors of low malignant potential. Obstet Gynecol. 2002;100(4):671-6.
OPR, PC and AID: all in the PB1 family. Trends Biochem Sci. 2002;27(1):10.
Molecular cloning and characterization of STAMP1, a highly prostate-specific six transmembrane protein that is overexpressed in prostate cancer. J Biol Chem. 2002;277(39):36689-96.
Humorally mediated posttransplantation septal capillary injury syndrome as a common form of pulmonary allograft rejection: a hypothesis. Transplantation. 2002;74(9):1273-80.
Protein-protein interactions monitored in mammalian cells via complementation of beta -lactamase enzyme fragments. Proc Natl Acad Sci U S A. 2002;99(6):3469-74.
CDK inhibitor p18(INK4c) is required for the generation of functional plasma cells. Immunity. 2002;17(2):179-89.